(CRWD) Crowdstrike Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US22788C1053
Stock: Endpoint, Cloud, Identity, Data, SaaS
Total Rating 30
Risk 67
Buy Signal -0.55
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 66.4% |
| Relative Tail Risk | -3.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -26.97 |
| Character TTM | |
|---|---|
| Beta | 1.530 |
| Beta Downside | 1.170 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.44% |
| CAGR/Max DD | 1.22 |
Description: CRWD Crowdstrike Holdings January 27, 2026
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) delivers a unified, cloud-native cybersecurity platform-Falcon-that secures endpoints, cloud workloads, identities, data, and SaaS applications through a subscription-based SaaS model. The suite spans endpoint protection, workload security, vulnerability management, identity protection, threat intelligence, AI-driven automation, and security-orchestration services, all sold primarily as recurring subscriptions.
As of the most recent fiscal quarter (Q3 FY2024), CrowdStrike reported annual recurring revenue (ARR) of $3.2 billion, representing a 38% year-over-year increase, and a net dollar retention rate of 150%, indicating strong upsell and cross-sell momentum. Gross margins remained robust at 84%, while the company’s subscription backlog grew to $4.1 billion, underscoring the durability of its recurring revenue base. The broader cybersecurity market continues to expand at a ~12% compound annual growth rate, driven by accelerated cloud migration, remote-work adoption, and rising regulatory pressure on data protection.
For a deeper, data-driven assessment of CrowdStrike’s valuation dynamics, you may find ValueRay’s analytical tools useful for further research.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -314.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -2.54 > 1.0 |
| NWC/Revenue: 63.95% < 20% (prev 60.89%; Δ 3.05% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.46b > Net Income -314.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (251.3m) vs 12m ago 2.36% < -2% |
| Gross Margin: 74.27% > 18% (prev 0.75%; Δ 7352 % > 0.5%) |
| Asset Turnover: 51.44% > 50% (prev 48.06%; Δ 3.38% > 0%) |
| Interest Coverage Ratio: -6.92 > 6 (EBITDA TTM -14.6m / Interest Expense TTM 27.1m) |
Altman Z'' 1.12
| A: 0.29 (Total Current Assets 6.52b - Total Current Liabilities 3.60b) / Total Assets 9.97b |
| B: -0.13 (Retained Earnings -1.30b / Total Assets 9.97b) |
| C: -0.02 (EBIT TTM -187.8m / Avg Total Assets 8.87b) |
| D: -0.22 (Book Value of Equity -1.30b / Total Liabilities 5.91b) |
| Altman-Z'' Score: 1.12 = BB |
Beneish M -2.95
| DSRI: 1.02 (Receivables 1.01b/813.9m, Revenue 4.57b/3.74b) |
| GMI: 1.01 (GM 74.27% / 75.24%) |
| AQI: 1.12 (AQ_t 0.25 / AQ_t-1 0.22) |
| SGI: 1.22 (Revenue 4.57b / 3.74b) |
| TATA: -0.18 (NI -314.2m - CFO 1.46b) / TA 9.97b) |
| Beneish M-Score: -2.95 (Cap -4..+1) = A |
What is the price of CRWD shares?
As of February 07, 2026, the stock is trading at USD 395.50 with a total of 4,939,262 shares traded.
Over the past week, the price has changed by -10.40%, over one month by -13.71%, over three months by -25.73% and over the past year by -5.95%.
Over the past week, the price has changed by -10.40%, over one month by -13.71%, over three months by -25.73% and over the past year by -5.95%.
Is CRWD a buy, sell or hold?
Crowdstrike Holdings has received a consensus analysts rating of 4.27.
Therefore, it is recommended to buy CRWD.
- StrongBuy: 27
- Buy: 12
- Hold: 11
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CRWD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 554.3 | 40.2% |
| Analysts Target Price | 554.3 | 40.2% |
| ValueRay Target Price | 469.2 | 18.6% |
CRWD Fundamental Data Overview February 07, 2026
P/E Forward = 85.4701
P/S = 20.8276
P/B = 26.0704
P/EG = 3.4264
Revenue TTM = 4.57b USD
EBIT TTM = -187.8m USD
EBITDA TTM = -14.6m USD
Long Term Debt = 745.1m USD (from longTermDebt, last quarter)
Short Term Debt = 15.9m USD (from shortTermDebt, last quarter)
Debt = 818.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.98b USD (from netDebt column, last quarter)
Enterprise Value = 91.10b USD (95.08b + Debt 818.0m - CCE 4.80b)
Interest Coverage Ratio = -6.92 (Ebit TTM -187.8m / Interest Expense TTM 27.1m)
EV/FCF = 78.83x (Enterprise Value 91.10b / FCF TTM 1.16b)
FCF Yield = 1.27% (FCF TTM 1.16b / Enterprise Value 91.10b)
FCF Margin = 25.31% (FCF TTM 1.16b / Revenue TTM 4.57b)
Net Margin = -6.88% (Net Income TTM -314.2m / Revenue TTM 4.57b)
Gross Margin = 74.27% ((Revenue TTM 4.57b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = 75.59% (prev 73.46%)
Tobins Q-Ratio = 9.14 (Enterprise Value 91.10b / Total Assets 9.97b)
Interest Expense / Debt = 0.85% (Interest Expense 6.93m / Debt 818.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -148.4m (EBIT -187.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.81 (Total Current Assets 6.52b / Total Current Liabilities 3.60b)
Debt / Equity = 0.20 (Debt 818.0m / totalStockholderEquity, last quarter 4.02b)
Debt / EBITDA = 272.4 (negative EBITDA) (Net Debt -3.98b / EBITDA -14.6m)
Debt / FCF = -3.45 (Net Debt -3.98b / FCF TTM 1.16b)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.54% (Net Income -314.2m / Total Assets 9.97b)
RoE = -8.66% (Net Income TTM -314.2m / Total Stockholder Equity 3.63b)
RoCE = -4.30% (EBIT -187.8m / Capital Employed (Equity 3.63b + L.T.Debt 745.1m))
RoIC = -3.40% (negative operating profit) (NOPAT -148.4m / Invested Capital 4.37b)
WACC = 11.46% (E(95.08b)/V(95.90b) * Re(11.55%) + D(818.0m)/V(95.90b) * Rd(0.85%) * (1-Tc(0.21)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF Debug] Terminal Value 70.87% ; FCFF base≈1.13b ; Y1≈1.40b ; Y5≈2.38b
Fair Price DCF = 109.0 (EV 23.49b - Net Debt -3.98b = Equity 27.47b / Shares 252.1m; r=11.46% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 32.85 | EPS CAGR: -34.81% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.85 | Revenue CAGR: 32.39% | SUE: 1.85 | # QB: 2
EPS next Quarter (2026-04-30): EPS=1.06 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=40
EPS next Year (2027-01-31): EPS=4.83 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+30.0% | Growth Revenue=+22.1%
P/S = 20.8276
P/B = 26.0704
P/EG = 3.4264
Revenue TTM = 4.57b USD
EBIT TTM = -187.8m USD
EBITDA TTM = -14.6m USD
Long Term Debt = 745.1m USD (from longTermDebt, last quarter)
Short Term Debt = 15.9m USD (from shortTermDebt, last quarter)
Debt = 818.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.98b USD (from netDebt column, last quarter)
Enterprise Value = 91.10b USD (95.08b + Debt 818.0m - CCE 4.80b)
Interest Coverage Ratio = -6.92 (Ebit TTM -187.8m / Interest Expense TTM 27.1m)
EV/FCF = 78.83x (Enterprise Value 91.10b / FCF TTM 1.16b)
FCF Yield = 1.27% (FCF TTM 1.16b / Enterprise Value 91.10b)
FCF Margin = 25.31% (FCF TTM 1.16b / Revenue TTM 4.57b)
Net Margin = -6.88% (Net Income TTM -314.2m / Revenue TTM 4.57b)
Gross Margin = 74.27% ((Revenue TTM 4.57b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = 75.59% (prev 73.46%)
Tobins Q-Ratio = 9.14 (Enterprise Value 91.10b / Total Assets 9.97b)
Interest Expense / Debt = 0.85% (Interest Expense 6.93m / Debt 818.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -148.4m (EBIT -187.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.81 (Total Current Assets 6.52b / Total Current Liabilities 3.60b)
Debt / Equity = 0.20 (Debt 818.0m / totalStockholderEquity, last quarter 4.02b)
Debt / EBITDA = 272.4 (negative EBITDA) (Net Debt -3.98b / EBITDA -14.6m)
Debt / FCF = -3.45 (Net Debt -3.98b / FCF TTM 1.16b)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.54% (Net Income -314.2m / Total Assets 9.97b)
RoE = -8.66% (Net Income TTM -314.2m / Total Stockholder Equity 3.63b)
RoCE = -4.30% (EBIT -187.8m / Capital Employed (Equity 3.63b + L.T.Debt 745.1m))
RoIC = -3.40% (negative operating profit) (NOPAT -148.4m / Invested Capital 4.37b)
WACC = 11.46% (E(95.08b)/V(95.90b) * Re(11.55%) + D(818.0m)/V(95.90b) * Rd(0.85%) * (1-Tc(0.21)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF Debug] Terminal Value 70.87% ; FCFF base≈1.13b ; Y1≈1.40b ; Y5≈2.38b
Fair Price DCF = 109.0 (EV 23.49b - Net Debt -3.98b = Equity 27.47b / Shares 252.1m; r=11.46% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 32.85 | EPS CAGR: -34.81% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.85 | Revenue CAGR: 32.39% | SUE: 1.85 | # QB: 2
EPS next Quarter (2026-04-30): EPS=1.06 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=40
EPS next Year (2027-01-31): EPS=4.83 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+30.0% | Growth Revenue=+22.1%